CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
Follicular lymphoma is the second most diagnosed lymphoma in Western Europe. Significant advancements have considerably improved the survival of FL patients. However, 10-20% of these patients are refractory to standard treatments, and most of them will relapse. The treatment of follicular lymphoma...
Saved in:
| Main Authors: | Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2024-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://mjhid.org/mjhid/article/view/5577 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA
by: Ugo Testa, et al.
Published: (2023-10-01) -
The landscape of T-cell engagers for the treatment of follicular lymphoma
by: Alfredo Rivas-Delgado, et al.
Published: (2024-12-01) -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
by: Andrea Riccardo Filippi
Published: (2016-09-01) -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
by: Giuseppe Rossi, et al.
Published: (2016-11-01) -
Paediatric Primary Testicular Follicular Lymphoma : A Diagnostic Challenge
by: Aysha Suhana, et al.
Published: (2025-04-01)